Motley Fool Australia

Zelira Therapeutics Ltd (ASX: ZLD) Share Price and News

Price
Movement
52 Week Range
-
1 Year Return
(20 mins delayed)

() Chart and Price Data

.

Share Price
Previous Close
Volume
Day Change
Open
Monthly Average Volume
52 Week Range -
Days Range -
Turnover

Fundamental Company Figures

Data provided by Morningstar.
Market Cap $72.61 million
P/E Ratio N/A
Dividend Yield N/A
Shares Outstanding 1.19 billion
Earnings per share -0.008
Dividend per share N/A
Year To Date Return -31.52%
Earnings Yield N/A
Franking N/A

Zelira Therapeutics Ltd (ASX: ZLD) Latest News

What will Elite Cannabinoids mean for ASX cannabis shares?

More »

ASX Cannabis share price represented by asx investor holding card with cannabis leaf on it

CBD to be sold in pharmacies, ASX cannabis shares react

More »

cannabis leaves on a rising line graph representing growth of ASX cannabis shares

The sector that’ll grow 480% this year, expert says

More »

medical marijuana, cannabis, pot, drug, medical

5 top ASX cannabis shares in 2020

More »

man walking up line graph, into clouds, representing asx shares at an all time high

Here’s why the Zelira (ASX:ZLD) share price just rocketed to a new high

More »

medical marijuana, cannabis, pot, drug, medical

THC Global share price surges 11% higher on cannabis production update

More »

medical marijuana, cannabis, pot, drug, medical

Why this ASX cannabis share jumped 7.5% higher today

More »

ASX marijuana shares

Should you still be invested in ASX marijuana shares?

More »

Recent Stock Announcements

Price Sensitive Only$An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Show All
Date Heading $An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security. Time Pages File Size
 

About Zelira Therapeutics Ltd (ASX: ZLD)

Zelira Therapeutics Ltd (ASX: ZLD) is a leading global therapeutic medicinal cannabis company with access to the world’s fastest growing cannabis markets. Formerly Zelda Therapeutics, Zelira owns a portfolio of proprietary products and a pipeline of candidates undergoing clinical development.

The company focus is on developing branded cannabis products for the treatment of a variety of medical conditions, including insomnia, autism and opioid reduction. Zelira has launched two proprietary formulations under the HOPE brand for autism in multiple US-states with plans to expand into global markets in 2020. 

Share Price History

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
12 Apr 2021 $0.06 $0.00 0.00% 868,774 $0.06 $0.06 $0.06
09 Apr 2021 $0.06 $0.00 0.00% 771,625 $0.06 $0.06 $0.06
08 Apr 2021 $0.06 $0.00 0.00% 1,038,573 $0.06 $0.06 $0.06
07 Apr 2021 $0.06 $0.00 0.00% 653,685 $0.06 $0.06 $0.06
06 Apr 2021 $0.06 $0.00 0.00% 756,108 $0.06 $0.06 $0.06
01 Apr 2021 $0.06 $0.00 0.00% 1,155,916 $0.06 $0.06 $0.06
31 Mar 2021 $0.06 $0.00 0.00% 984,106 $0.06 $0.06 $0.06
30 Mar 2021 $0.06 $0.00 0.00% 1,932,044 $0.06 $0.06 $0.06
29 Mar 2021 $0.06 $0.00 0.00% 5,628,144 $0.06 $0.06 $0.06
26 Mar 2021 $0.06 $0.00 0.00% 2,834,253 $0.07 $0.07 $0.06
25 Mar 2021 $0.06 $0.00 0.00% 942,823 $0.06 $0.07 $0.06
24 Mar 2021 $0.06 $0.00 0.00% 821,137 $0.07 $0.07 $0.06
23 Mar 2021 $0.07 $0.00 0.00% 1,069,966 $0.07 $0.07 $0.07
22 Mar 2021 $0.07 $0.00 0.00% 1,030,171 $0.07 $0.07 $0.07
19 Mar 2021 $0.07 $0.00 0.00% 1,527,421 $0.07 $0.07 $0.07
18 Mar 2021 $0.07 $0.00 0.00% 1,627,215 $0.07 $0.07 $0.07
17 Mar 2021 $0.07 $0.00 0.00% 904,031 $0.07 $0.07 $0.07
16 Mar 2021 $0.07 $0.00 0.00% 3,654,678 $0.06 $0.07 $0.06
15 Mar 2021 $0.06 $0.00 0.00% 1,307,402 $0.06 $0.06 $0.06
Show more

Director Transactions

Data provided by Morningstar.
Date Director Type Amount Value Notes
05 Oct 2020 Lisa Gray Sell 8 $607,281
11 Aug 2020 Richard Hopkins Issued 1 $50,000
11 Aug 2020 Oludare Odumosu Issued 25 $1,300,000


Directors & Management

Data provided by Morningstar.
Name Title StartDate Profile
Mr Harry Karelis Executive Director,Executive Deputy Chairman Nov 2016
Dr Richard Miles Hopkins Chief Executive Officer,Managing Director Jul 2018
Mr Jason William Peterson Non-Executive Director Nov 2016
Dr Oludare Odumosu Managing Director (USA) Dec 2019
Mr Osagie Imasogie Non-Executive Chairman,Non-Executive Director Dec 2019
Ms Lisa Gray Non-Executive Director Dec 2019
Mr Timothy (Tim) Ryan Slate Company Secretary Dec 2016
Timothy (Tim) Ryan Slate Company Secretary
Show more

Top Share Holders

Data provided by Morningstar.
Name Shares Capital
Sunset Capital Management Pty Ltd 55,413,617 4.85%
Gemelli Nominees Pty Ltd 49,587,680 4.34%
Mara Gordon 44,142,326 3.86%
Mal Washer Nominees Pty Ltd 35,198,688 3.08%
Capricorn Investment Partners (Nominees) Pty Ltd 17,577,883 1.54%
Citicorp Nominees Pty Limited 16,756,434 1.47%
HSBC Custody Nominees (Australia) Limited 16,699,968 1.46%
Mr Torsten M Geers 16,413,065 1.44%
Mr Zoltan Kerekes 16,413,065 1.44%
Ms Lisa Gray 16,413,065 1.44%
Osagie Imasogie 16,413,065 1.44%
Sharri J Rochlin 16,413,065 1.44%
Ubs Nominees Pty Ltd 15,800,000 1.38%
JP Morgan Nominees Australia Pty Limited 13,930,688 1.22%
Mera I LLC \C 13,879,566 1.22%
Mr Amit Gupta 11,529,999 1.01%
Celtic Capital Pty Ltd 11,200,000 0.98%
Copper Lake Holdings Limited 10,075,203 0.88%
Mr Alan Trounson 10,075,203 0.88%
Xena Advisors Llc 8,888,889 0.78%
Show more